Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 2 |
2012 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.
Cancer Prev Res (Phila). 2012 Apr;5(4):583-92. doi: 10.1158/1940-6207.CAPR-11-0482. Epub 2012 Feb 7.
Cancer Prev Res (Phila). 2012.
PMID: 22318751
Free PMC article.
Bevacizumab added to neoadjuvant chemotherapy for breast cancer.
Bear HD, Tang G, Rastogi P, Geyer CE Jr, Robidoux A, Atkins JN, Baez-Diaz L, Brufsky AM, Mehta RS, Fehrenbacher L, Young JA, Senecal FM, Gaur R, Margolese RG, Adams PT, Gross HM, Costantino JP, Swain SM, Mamounas EP, Wolmark N.
Bear HD, et al.
N Engl J Med. 2012 Jan 26;366(4):310-20. doi: 10.1056/NEJMoa1111097.
N Engl J Med. 2012.
PMID: 22276821
Free PMC article.
Clinical Trial.
Item in Clipboard
Using cure models and multiple imputation to utilize recurrence as an auxiliary variable for overall survival.
Conlon AS, Taylor JM, Sargent DJ, Yothers G.
Conlon AS, et al.
Clin Trials. 2011 Oct;8(5):581-90. doi: 10.1177/1740774511414741. Epub 2011 Sep 15.
Clin Trials. 2011.
PMID: 21921063
Free PMC article.
Item in Clipboard
Effect of occult metastases on survival in node-negative breast cancer.
Weaver DL, Ashikaga T, Krag DN, Skelly JM, Anderson SJ, Harlow SP, Julian TB, Mamounas EP, Wolmark N.
Weaver DL, et al.
N Engl J Med. 2011 Feb 3;364(5):412-21. doi: 10.1056/NEJMoa1008108. Epub 2011 Jan 19.
N Engl J Med. 2011.
PMID: 21247310
Free PMC article.
Clinical Trial.
Item in Clipboard
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Wolmark N.
Krag DN, et al.
Lancet Oncol. 2010 Oct;11(10):927-33. doi: 10.1016/S1470-2045(10)70207-2.
Lancet Oncol. 2010.
PMID: 20863759
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite